指导系统性自身免疫性风湿病的 ILD 管理

IF 29.4 1区医学 Q1 RHEUMATOLOGY

Nature Reviews Rheumatology Pub Date : 2024-09-04 DOI:10.1038/s41584-024-01160-2

Fabrizio Luppi, Marco Sebastiani

引用次数: 0

摘要

经过美国风湿病协会（ACR）和美国胸科医师学会（American College of Chest Physicians）多学科的共同努力，第一份关于系统性自身免疫性风湿病（SARDs）患者间质性肺病（ILD）的筛查、监测和治疗指南现已面世。这些指南表明，多学科合作可以改善 SARD-ILD 的管理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Guiding ILD management in systemic autoimmune rheumatic diseases

The first guidelines for the screening, monitoring and treatment of interstitial lung disease (ILD) in patients with systemic autoimmune rheumatic diseases (SARDs) are now available after a major multidisciplinary effort by the ACR and the American College of Chest Physicians. These guidelines demonstrate that multidisciplinary collaborations can improve SARD-ILD management.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Nature Reviews Rheumatology 医学-风湿病学

CiteScore

29.90

自引率

0.90%

发文量

137

审稿时长

6-12 weeks

期刊介绍： Nature Reviews Rheumatology is part of the Nature Reviews portfolio of journals. The journal scope covers the entire spectrum of rheumatology research. We ensure that our articles are accessible to the widest possible audience.